These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36463728)

  • 1. Discovery of the novel Benzo[b]thiophene 1,1-dioxide derivatives as a potent STAT3 inhibitor against idiopathic pulmonary fibrosis.
    Wang Y; Liu H; Li W; Xie Y; Gan C; Xue T; Su X; Yue L; Wang Q; Fan C; Zhang Y; Ye T
    Eur J Med Chem; 2023 Jan; 246():114953. PubMed ID: 36463728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
    Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
    Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of novel diarylacylhydrazones derivatives for the efficient treatment of idiopathic pulmonary fibrosis.
    Su X; Tan Z; Wang G; Liu Z; Gan C; Yue L; Liu H; Xie Y; Yao Y; Ye T
    Eur J Med Chem; 2023 Jan; 245(Pt 2):114918. PubMed ID: 36401884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TGF-β1/Smad3 signaling by compound 5aa: A potential treatment for idiopathic pulmonary fibrosis.
    An B; Fang Y; Wang L; Nie W; Wang M; Nie H; Wu C; Wang R
    Bioorg Chem; 2024 Jun; 147():107374. PubMed ID: 38636433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
    Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
    Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
    Qian W; Cai X; Qian Q; Zhang W; Wang D
    J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway.
    Ruan H; Gao S; Li S; Luan J; Jiang Q; Li X; Yin H; Zhou H; Yang C
    Molecules; 2021 May; 26(9):. PubMed ID: 34068694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.
    Chen YL; Zhang X; Bai J; Gai L; Ye XL; Zhang L; Xu Q; Zhang YX; Xu L; Li HP; Ding X
    Cell Death Dis; 2013 Jun; 4(6):e665. PubMed ID: 23764846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study.
    Gan C; Zhang Q; Liu H; Wang G; Wang L; Li Y; Tan Z; Yin W; Yao Y; Xie Y; Ouyang L; Yu L; Ye T
    Respir Res; 2022 Feb; 23(1):32. PubMed ID: 35172837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
    Chen S; Wei Y; Li S; Miao Y; Gu J; Cui Y; Liu Z; Liang J; Wei L; Li X; Zhou H; Yang C
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109316. PubMed ID: 36252483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.
    Liang H; Gu Y; Li T; Zhang Y; Huangfu L; Hu M; Zhao D; Chen Y; Liu S; Dong Y; Li X; Lu Y; Yang B; Shan H
    Cell Death Dis; 2014 May; 5(5):e1238. PubMed ID: 24853416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
    Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
    Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
    Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS
    EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-butyldeoxynojirimycin (miglustat) ameliorates pulmonary fibrosis through inhibition of nuclear translocation of Smad2/3.
    Nakamura H; Zhou Y; Sakamoto Y; Yamazaki A; Kurumiya E; Yamazaki R; Hayashi K; Kasuya Y; Watanabe K; Kasahara J; Takabatake M; Tatsumi K; Yoshino I; Honda T; Murayama T
    Biomed Pharmacother; 2023 Apr; 160():114405. PubMed ID: 36804125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis.
    Boehme SA; Franz-Bacon K; DiTirro DN; Ly TW; Bacon KB
    PLoS One; 2016; 11(5):e0154874. PubMed ID: 27144281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
    Deng W; Zhang Y; Fang P; Shi H; Yang S
    Environ Toxicol; 2022 Oct; 37(10):2375-2387. PubMed ID: 35785413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis.
    Ahangari F; Becker C; Foster DG; Chioccioli M; Nelson M; Beke K; Wang X; Justet A; Adams T; Readhead B; Meador C; Correll K; Lili LN; Roybal HM; Rose KA; Ding S; Barnthaler T; Briones N; DeIuliis G; Schupp JC; Li Q; Omote N; Aschner Y; Sharma L; Kopf KW; Magnusson B; Hicks R; Backmark A; Dela Cruz CS; Rosas I; Cousens LP; Dudley JT; Kaminski N; Downey GP
    Am J Respir Crit Care Med; 2022 Dec; 206(12):1463-1479. PubMed ID: 35998281
    [No Abstract]   [Full Text] [Related]  

  • 20. Daphnetin Alleviates Bleomycin-Induced Pulmonary Fibrosis through Inhibition of Epithelial-to-Mesenchymal Transition and IL-17A.
    Park SJ; Ryu HW; Kim JH; Hahn HJ; Jang HJ; Ko SK; Oh SR; Lee HJ
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.